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Breast cancer imaging is a good example of how medical imaging modalities can diminish the
number of patients suffering from this highly prevalent and deadly disease. X-ray mammog‐
raphy is the most used technique for breast cancer imaging. This technique is used either as a
complementary tool to clinical diagnosis or as an irreplaceable screening tool for the early
detection of the disease. However, it suffers from low specificity in the detection of malignancy
and low sensitivity in women with dense breast tissue. Other imaging methods such as breast
Ecography and breast Magnetic Resonance Imaging play important roles as adjunct techniques
to X-ray mammography. The information provided by the aforementioned techniques is,
however, mainly anatomical, thus leaving space for imaging methods that are able to obtain
information regarding functional or metabolic changes in tissues.
Among these, molecular imaging methods using labeled radiotracers such as Scintigraphy,
SPECT, Positron Emission Tomography (PET) and PET-CT, have been found to provide useful
complementary information to the anatomical methods regarding detection, diagnosis and
staging of breast cancer. However, the standard technology of whole body scanners, due to its
limited spatial resolution, and to its disadvantageous geometry, which limits sensitivity, have
in part precluded molecular imaging using radiotracers from contributing with its full
potential to the imaging of the breast.
These limitations have prompted an active interest in the development of compact positron
emission tomography cameras dedicated for breast imaging, a technique named Positron
Emission Mammography. In the last 20 years there has been a tremendous effort from the
industry and the scientific community to develop such devices, with a variety of detector
designs and geometries, innovative radiation detection schemes, new scintillation crystals and
adapted image reconstruction algorithms being studied in order to optimize the technique.
© 2015 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
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Either as prototypes or as commercial equipment, PEM scanners have provided data that
confirms a huge improvement in technical characteristics with regards to whole body scanner,
thus showing great promise of becoming a valuable modality in the clinical practice. In fact,
Positron Emission Mammography, for which there are now two commercial equipment
available, has demonstrated higher detectability than PET/CT and comparable or better
sensitivity than MRI. It seems now to be clear that PEM is a valuable technique when MRI
cannot be used.
In this chapter we will present a review from the literature of the main equipment that have
been developed for Positron Emission Mammography, emphasizing the different approaches
that have been followed in the design of the scanners, the main technical outcomes and, when
such information is available, the most significant results obtained in the clinical trials.
The chapter will begin with a brief description of the principles behind the tomographic
method for molecular imaging of positron emission isotopes. We will then review the per‐
formance parameters and instrumentation issues more challenging in the design of dedicated
PEM scanners. We will review the PEM clinical results available so far, which allow a direct
comparison between PEM, PET and MRI, and which give some clues regarding the clinical
utility of PEM.
2. Positron emission mammography technology
The principles underlying Positron Emission Mammography are similar to those of Positron
Emission Tomography. However, since there is a requirement for high resolution and high
sensitivity, specific instrumentation issues are raised during the design and development of
PEM scanners. This section will begin by presenting the principles of positron emission
detection for medical imaging purposes; then, the key factors regarding the technical per‐
formance of the scanner will be presented. A very brief overview on the most important issues
regarding the image reconstruction will also be presented.
2.1. Positron emission and detection
Positron Emission Mammography, as well as Positron Emission Tomography, uses radio‐
pharmaceuticals that are labeled with a positron emitting radionuclide.
The most used radiopharmaceutical for imaging cancer in PET is 18F-fluorodeoxyglucose, or
18F-FDG, a glucose analogue that is labeled with the positron emitter 18F. This radiotracer is
used to detect glucose consumption, which is known to be increased in cancerous cells
compared to normal cells. This is due to the higher metabolism of cancerous cells. The
advantage of being able to image metabolism instead of anatomy, like in CT, is that the
accelerated metabolic activity of cancerous cells occurs before the changes in the anatomical
structures are detectable.
The tracking mechanism of 18FDG inside the cancerous cells is as follows. FDG is a glucose
analog and, just like glucose, is transported into the cells by glucose transporters named
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GLUT1. These transporters are known to be overexpressed in breast cancerous cells, thus
contributing to increased FDG uptake [1]. Once inside the cell, FDG is phosphorylated into
deoxyglucose-6-phosphate (FDG-6-PO4) by an enzyme named hexokinase. Hexokinase is also
thought to be overexpressed in cancerous cells. Unlike glucose, FDG-6-PO4 does not enter
further enzymatic reactions and, due to its negative charge, it remains trapped inside the cell
[2]. This metabolic trapping of FDG inside the cell constitutes the basis for imaging the in vivo
distribution of the tracer.
Besides 18F, other radionuclides, such as 82Rb, 15O, 13N and 11C, among others, can be used to
label the molecular probes used in PET.
Once emitted from the radiopharmaceutical, the positron travels a given amount of space in
matter, while dissipating its kinetic energy through interactions with electrons and surround‐
ing nuclei. At the end of its path, the positron combines with an electron in its vicinity, in an
annihilation reaction whereby the total mass of the electron and the positron is converted into
high energy photons. The rest-mass energy of both positron and electron is 511 keV. If both
particles are at rest at the time of annihilation, the two resulting 511 keV photons will be emitted
in opposite directions.
The gamma rays thus emitted can interact with the tissues of the patient either by photoelectric
effect or by Compton scatter. Both photon attenuation and scatter result in image degradation
since, in the first case, emission counts are lost and, in the second, the measured spatial
information is inaccurate. Whereas the correction for the effect of attenuation is fairly simple
if a transmission scan is available, the correction for the scatter effect not as straightforward.
If the photons are not absorbed by the matter in the patient body, they can be detected
externally in coincidence by using opposed pairs of scintillator crystals. Each luminous signal
produced in the crystals is transformed into an electrical signal. A coincidence event happens
when such two electrical signals are registered in a coincidence electronic circuit within a time
frame that is defined by a coincidence time window.
The imaginary line that unites the two activated crystals in a coincidence event is called a line
of response (LOR). The number of counts that are detected along the several LORs during an
exam is stored in an histogram and used for image reconstruction purposes. Alternatively, list
mode format can be used. In list mode format, the relevant information regarding the event,
such as the activated crystals, the deposited energy and a time stamp, is stored sequentially
on disk and used directly for image reconstruction.
2.2. The performance of a scanner
Of main importance for the performance of a PET scanner are its photon sensitivity and its
spatial, energy and temporal resolutions. The geometry, the detector crystals and the elec‐
tronics of the system all impact on the above. In this paragraph we will overview the main
aspects that affect these parameters, highlighting the most common differences between
traditional clinical scanners and high resolution scanners.
The photon sensitivity is defined as the fraction of 511 keV photon pairs emitted from the




the higher photon sensitivity possible since a higher fraction of detected photons will impact
on better statistics of the acquired data and, consequently, on lower noise level of the final
reconstructed images. The photon sensitivity in a clinical PET system is low. In dedicated or
high resolution scanners, The sensitivity is usually improved by increasing the scanner
geometric efficiency, that is, the probability that the emitted photon transverses the detected
material, or by increasing the intrinsic detector efficiency.
Usually, the scanner geometric efficiency is enhanced in dedicated scanners relatively to
traditional scanners mainly because the detector is brought closer to the imaging subject.
The geometric efficiency can also be increased by packing the detector elements as tightly as
possible and by covering the region to be imaged with as much detector as possible. The other
aspect that influences the scanner photon sensitivity is the intrinsic detector efficiency. This is
defined as the likelihood that photons transversing the detector material will be stopped [3].
It depends mainly on the scintillator crystals that are used as detector elements. Scintillator
crystals that have high density (ρ), with high effective atomic number (Zeff) have maximum
ability to stop the 511 keV photons. In fact, a high density crystal favors the photon interaction
and a high effective atomic number maximizes the probability of photoelectric interactions
within the crystal, with respect to Compton events. The quantity that maximizes the crystal
stopping power is ρ.Zeff5. A scintillator that has a high stopping power will have a short
attenuation length.
Table 1 lists the values of Zeff, ρ, the attenuation length and some other properties of the most
common scintillator crystals used in PET scanners. The decay time determines the time
resolution of the scanner and the light output determines the detector energy resolution and
has effects also in the image resolution. Both these parameters will be discussed later.
Sodium iodide doped with thallium (NaI(Tl)) was the detector initially used in PET scanners.
It has a very high light output (38 photons/keV), resulting in good energy and spatial resolu‐
tions [4]. However, its slow decay time leads to increased detector dead time and a high
random coincidence rate (see below the discussion for system time resolution). Its low density
results in a low stopping power (high attenuation length) when compared to the other crystals
used in PET. Sodium iodine was first replaced by BGO (bismuth germanate: Bi4Ge3O12) that,
despite its high decay time and poor light output, has an excellent stopping power.
More recently, other crystals that combine better light output with high stopping power have
been introduced to PET. LSO (lutetium oxyorthosilicate: Lu2SiO5) has a high stopping power
and a good light yield but, due to intrinsic properties of the crystal, its overall resolution is not
as good as NaI(Tl) [5]. GSO (gadolinium orthosilicate: Gd2SiO5), despite its lower stopping
power and light output, has better energy resolution than LSO. Both crystals are in use in PET
scanners.
The spatial resolution describes the ability of the system to distinguish two closely spaced
point sources. In PET, the fundamental limit of spatial resolution is imposed by the nature of
positron annihilation. In fact, the emitted positron describes, before annihilating, a given path
of variable length and direction. Therefore, the detected LOR contains the positron annihilation
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point, not the positron emission point, and these two points can be several millimeters apart.
This positron range effect degrades the spatial resolution of the images. (Figure 1a). The
positron range depends upon the energy of the emitted positron and upon the electronic
density of the medium. It has been estimated a value of 0.22 mm FWHM for the positron range
emitted from 18F in water, the major component of human cells [7].
In addition to the positron range, the acollinearity effect also leads to resolution degradation
in PET systems. This effect is caused by the fact that the annihilation photons are almost never
anti-parallel, since usually the positron and the electron are not exactly at rest when they
annihilate. As a consequence, the detected line of response does not contain the point of
positron-electron annihilation (Figure 1b). The degradation of the spatial resolution due to the
accolinearity effect worsens as the detector diameter increases.
Another significant factor that limits PET spatial resolution is the size of the detector element.
Spatial resolution may be improved significantly by reducing the detector pixel size. This is
especially important in small diameter or dedicated PET scanners, where the pixel size
dominates image resolution over the non-collinearity effect, which is minor for small detector
diameters. Typical clinical systems use 4.0−6.0 mm detector pixel sizes, whereas small animal
use detector pixels of 1.5−2.0 mm and positron emission mammography scanners use pixel
sizes of 1.8−3.0 mm.
A final important factor that affects PET spatial resolution is the parallax error. This error
occurs when the crystal depth at which the photon interaction takes place, known as Depth of
Interaction (DOI), is not known. In this case, the LOR that unites the two activated crystals
does not necessarily contain the true LOR (Figure 1c). For photons entering the scintillators at
oblique angles there will be a mismatch between the true and the measured line of response.
This degrading effect has greater impact in scanners where the distance between opposed
detectors is smaller, like dedicated cameras. Good spatial resolution is of crucial importance
for these cameras.
Table 1. Properties of common scintillator crystals used in positron emission tomography.Adapted from [3] and from




To improve photon sensitivity, the scintillator crystals that compose these dedicated scanners
are usually long crystals. Therefore, not surprisingly, the ability to obtain DOI information has
become an important factor in the design of high resolution PET scanners [8], with different
strategies being followed to perform such measurements.
Figure 1. Schematic drawings of some of the effects that degrade spatial resolution in PET: a) the positron range, b) the
accolinearity effect and c) the Depth of Interaction effect or parallax error.
The energy resolution indicates the precision with which the system can measure the incoming
photon energy. A good energy resolution is important because it allows the use of a narrow
energy window without significantly compromising photon sensitivity.
A narrow energy window helps to prevent contamination from photons that undergo scatter
before interacting with the scintillator crystal, since the scatter process implies the loss of
energy. It may also help to reduce the rate of random photon events, since a part of these
photons undergo scatter. Random, or accidental, coincidences, occur when photons proceed‐
ing from different annihilations are detected within a same timing window and, although
spatially uncorrelated, its detection is considered as a valid coincidence.
Energy resolution may be improved by using crystals with hight scintillation light output. A
typical value for clinical PET scanners energy resolution is 25% FWHM at 511 keV [3].
The time resolution determines how well the system can decide whether two incoming
photons arrived simultaneously. Good time resolution allows the use of a narrow time
window, thus reducing random event’s detection without compromising photon sensitivity.
The reducing of random events is also important as it helps to prevent the system from
saturating in high count statistics studies. The parameter that most strongly determines the
temporal coincidence timing window is the scintillator decay time: a fast scintillator allows
the selection of a narrow time window. A typical value for clinical PET scanners time resolution
is 3 ns FWHM at 511 keV [3].
The scintillation light from the crystals is read from photodetectors. In PET, are most com‐
monly either photomultiplier tubes (PMT) or semiconductor based photodiodes. Photomul‐
tiplier tubes are the oldest and most reliable technology to detect and measure low levels of
scintillation light. They have a high gain in the photoelectric conversion, which leads to high
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signal-to-noise ratios. Besides simple PMT’s, a class of PMTs has been developed that provides
not only energy information but also spatial information about the detected light. These PMTs,
named Position-Sensitive PMTs (PS-PMT) have been found to be useful in the design of high
resolution PET scanners [9].
PMTs have two major drawbacks. They have low quantum efficiency, meaning that the ratio
between the incident photons and the primary produced electrons is low. In addition, PMTs
are big devices, often with a small field of view, and this may constitute a drawback, especially
when they are to be used in small dedicated scanners. In recent years there has also been great
progress in the development of semiconductor photodetector arrays. These can be the PIN
photodiode, the avalanche photodiode (APD) and the silicon drift detector (SDD). Among
these, the APDs are the most used in PET cameras. Semiconductor photodetectors have many
advantages over PMTs: they are very compact; they are insensitive to magnetic fields, which
makes them good candidates for PET-MRI devices; they are available with large active areas;
they have a very high efficiency [10]. The main disadvantages of APDs are their sensitivity to
temperature and bias voltage.
2.3. Image reconstrucion
For many years, the problem of reconstructing an image from the projection data acquired in
Positron Emission Tomography was addressed with analytic approaches which were inherited
from X-ray computed tomography. Analytic algorithms such as filtered backprojection (FBP)
are based on the direct inversion of the Radon transform. They are fast, linear, predictable, and
their properties are very well known. The inversion of the Radon transform is derived for a
continuous sampling and discretized afterward for sampled data [99]. Analytic algorithms are
based on an idealized mathematical model for the data, the linear integral model, according
to which the number of coincidence photon pairs detected along a LOR is approximately
linearly proportional to the integral of the tracer density along a LOR. This model over-
simplifies the physics inherent to the emission and detection processes in PET, limiting the
accuracy of the images reconstructed with analytical algorithms.
In alternative to the analytic image reconstruction algorithms, model based algorithms, which
can include accurate physical and statistical models of the systems, can be used. In opposition
to analytical algorithms, they incorporate the discreteness of the data from the beginning. Their
use usually results in improved image accuracy. As their formulation results frequently in
large sets of nonlinear equations that must be solved by iterative methods, this class of
algorithms is usually referred to as iterative image reconstruction algorithms. Furthermore, if
statistical functions are used to derive them, they are said to be statistical iterative reconstruc‐
tion algorithms. The use of iterative methods based on probability models for image recon‐
struction was already effective in the field of astronomy in the early 1970’s (Lucy, 1974,
Richardson 1972). Later, in 1976, Rockmore and Macovsky introduced the Maximum Likeli‐
hood approach in the field of medical imaging. The Ordered Subsets – Expectation Maximi‐
zation (OSEM) algorithm was proposed in 1994 by Hudson and Larkin as an accelerated
version of the ML-EM method and has since gained wide acceptance as a standard recon‐
struction method in PET. Nowadays, the most used algorithms for image reconstruction in




3. Positron emission mammography scanners
A design of a dedicated positron emission imaging system for breast cancer was first presented
in 1994 as a feasibility study for a positron emission mammography unit. Since then, more
than ten other systems have been developed, two of which have become commercially
available [11, 12]. Those systems differ in the number, geometry and mobility of the detectors
used, with consequences on the patient positioning; its ability or not to perform biopsy; the
different radiation detection scheme used, including different scintillation crystals; on the
strategies used for image reconstruction from the measured projections. In this section we will
review the instrumentation issues that impact on the performance of the equipment that use
positron emission mammography to image disease. We will emphasize on the most demand‐
ing aspects of these dedicated instruments, showing why they hold the promise for an
improved early detection of disease.
3.1. The PEM-I system
A design of a dedicated positron emission imaging system for breast cancer was first presented
in 1994 by Thompson [13] from the Montreal Neurological Institute of the McGill University,
Canada, as a feasibility study for a positron emission mammography unit.
The developed scanner was designed to fit a mammographic unit, so that conventional
mammograms could also be performed in the same gantry, thus allowing exact registration of
the emission and of the conventional mammographic images [14]. For such purposes, the
system included a co-registration tool to facilitate registration between radiographic and
metabolic images [15]. A schematic diagram of the scanner is presented in Figure 2.
The developed scanner consists on two planar 2x2 detector arrays of blocks of bismuth
germanate (BGO) crystals placed above and below the compressed breast. The detector blocks
measure 36x36x20 mm3 and are segmented into 1.9x1.9 mm2 pixels [16]. The separation
between the detector heads can be adjusted to match the thickness of the breast. The system
uses position sensitive photomultiplier tubes (PS-PMT) that are optically coupled to the crystal
blocks. Although the PS-PMTs cover a surface of 72x72 mm2, their useful field-of-view (FOV)
is only of 65x55 mm2. The coordinates of the coincidence on opposing PS-PMT faces are
decoded by the system electronics and corrected for spatial distortion and efficiency [17].
The images from this system are obtained by performing a limited-angle weighted-backpro‐
jection algorithm. This consists on dividing the image into several equidistant planes and
backprojecting the lines or response (LOR) onto those planes. With this technique, the image
plane closest to the site of the tumor has the most focused image, while all the other planes
present more blurred images, as it can be seen in the schematic diagram of Figure 3. This is
known as the focal plane effect. The reconstruction scheme is said to be ‘weighted backpro‐
jection’ because the values that are added to a given plane in the image matrix are weighted
accordingly to the probability of detection of an annihilation in that plane, the crystals
efficiencies and the photon attenuation along the path to the crystal [14].
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Figure 3. Weighted backprojection used in the PEM-I scanner. From [18].
The complete system has a spatial resolution of 2.8 mm FWHM, a time resolution of 12 ns and
an efficiency of 3% at a detector separation of 55 mm [19]. It is estimated that the system is not
able to detect tumors with a tumor-to-background ratio lower than 6:1 [20].
Figure 2. Schematic drawing of the PEM-I detector plates (white areas) mounted on a conventional mammographic




The preliminary clinical trials, performed with 16 subjects, reported 80% sensitivity and 100%
specificity. The accuracy of the exam, computed as the ratio of the sum of the true findings
(positive and negative) to the total number of lesions, was 86% [18]. For mammography exams
performed on the same subjects, those values were, respectively, 90%, 50% and 81%. The
smallest cancerous lesion detected with PEM-I was 1.1x1.1x0.9 cm3. The lower value of
sensitivity with PEM, with respect to mammography, was due, according to the authors, to
the small FOV of the PEM device and to the impossibility of imaging tumors localized close
to the chest wall (less than 2 cm). These limitations are related to the PMTs used, whose useful
field of view is significantly smaller than its area, preventing imaging near their edges. Figure
4 shows a typical set of images obtained with PEM-I, each image corresponding to a plane of
the sample, with a visible site of FDG uptake in a region close to the chest wall [19].
Figure 4. A typical set of images obtained with the PEM-I scanner. Each image corresponds to a plane, with the left‐
most image corresponding to the image plane closer to the upper detector. A visible site of FDG uptake can be seen in
a region close to the chest wall. From [19].
3.2. The Naviscan PEM system
The original idea of Thompson for a PEM system was further developed by Weinberg and
colleagues, for the Naviscan PET System. The Naviscan PEM Flex consists of two 5.6×17.3 cm2
opposed detector heads [21] that can be fit on a steriotactic mammography unit [22]. This way,
emission and transmission scans can be obtained. Data acquisition is performed by moving the
detectors along a linear path, in order to image as much breast as possible. The PEM detectors
translation allows to image an area equal to the entire X-ray field of view [23]. The system can
also work separately from the mammography unit, allowing closer chest wall access. Figure 5
shows the PEM Flex system mounted in a stereotactic X-ray mammography unit.
Each detector head contains twelve 13×13 crystal blocks, each coupled to a compact PS-PMT.
The crystals are 2×2×10 mm3 of a mixed-lutetium silicate [21].
For each segment of the scan, list mode data are acquired, histogrammed and reconstructed
by backprojection. This allows the operator to view partial images during the scan acquisition.
At the end of the entire scan, the complete list mode data are reconstructed using a maximum-
likelihood expectation-maximization algorithm.
The intrinsic spatial resolution of the system is 1.5 mm FHWM [23]. The image resolution is
2.5 mm FWHM in the plane perpendicular to the displacement and 6 mm between planes.
Energy resolution was measured as 14% for 511 keV. The timing window used was 9 ns.
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The clinical trials performed so far [24, 25] were all performed on patients with known breast
cancer or suspected lesions. Hence, they provide little information on the specificity of the
technique. In one of these studies [25], PEM was able to visualize 39 out of 44 lesions. The non
visualized lesions ranged in size from a 1 mm ductal carcinoma in situ (DCIS) to a 1 cm
infiltrating ductal carcinoma. Some lesions could not be visualized due to limitations on how
posterior the breast tissue is observable by the device. Others, as interpreted by the authors of
the study, due to the variability in the metabolic activity of breast cancer cells, similarly to what
happens with whole body PET.
Figure 6. Image of DCIS obtained with the PEM Flex scanner a), with MRI b) and with mammography c). Neither MRI
nor mammography could detect the DCIS lesion seen in the PEM image. From [25].
The most encouraging finding in this trial was the fact that PEM was able to visualize DCIS
not visualized by mammography, breast ecography or MRI. An example of such a case can be
seen in Figure 6. The smallest lesion detected by PEM in this study was a 2 mm duct of DCIS.
This preliminary clinical trial seems to indicate that the technology is promising and worthy
of further investigation.
3.3. The West Virginia University — Jefferson Lab PEM system
Another PEM system was developed and tested at the West Virginia University and at the
Jefferson Laboratory by Raylman and colleagues [26]. This PEM system, which is mounted on
a stereotactic biopsy table, consists of two square 10×10 cm2 detector arrays of discrete 3×3×10
mm3 GSO crystals. The scintillation light is collected by arrays of PS-PMTs. An image of the
scanner mounted on the biopsy table, together with a torso phantom can be seen in Figure 7.




Figure 7. Image of the West Virginia University - Jefferson Laboratory PEM system. The PEM detector heads, mounted
in a biopsy table, are highlighted by the black arrows. A torso phantom can be seen in the table. From [27].
Since one of the goals of the system is to perform PEM guided biopsies, a trigonometric
algorithm was developed to determine the lesion stereotactic coordinates. This algorithm uses
two PEM images that are acquired at two symmetric angles (±15◦).
PEM images acquired in a single detector position were initially reconstructed using a
weighted backprojection algorithm similar to the used for the PEM-I system described above,
or by a limited angle tomography scheme [23]. Later, the use of acquired data at two detector
positions (±15◦) [28] to guide stereotactic biopsy motivated the use of an adapted Maximum
Likelihood - Expectation Maximization algorithm.
The described acquisition scenario was compared with multiple acquisitions between the same
limiting angles, at small uniform increments [29]. The results were somehow mixed, with no
clear evidence of significant advantage of one acquisition scenario over the other, although
less artifacts were observed with the multiple angle acquisition.
This lead to a study of the complete angular sampling around the breast [30] through step and
shoot acquisitions. Not surprisingly, this study showed that the complete angular sampling
provided better image quality with respect to a single acquisition with stationary detectors.
The study also revealed some of the weaknesses of the system, such as the low rate acquisition
capability and the lack of DOI information.
Posterior work reports a new design of the scanner, now named PEM-PET [31], as it means to
be a tomographic system. This system has four planar detector heads that can rotate around
the breast. The detector crystal used is now LYSO, with 2×2×15 mm3 individual detector
elements. The PEM-PET system has 2 mm FHWM resolution, possessing, as its anterior
version, the ability to guide biopsy. The initial clinical studies have shown the ability of the
system to detect lesions also detected by standard methods [32].
3.4. The Duke University — Jefferson Lab PEM system
Another system was developed at the Jefferson Laboratory and Duke University to image the
compressed breast [33]. This PEM system has two opposed planar 15×20 cm2 detectors that
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acquire data without rotational or translational movements. The detector arrays are composed
of 3×3×10 mm3 of lutetium gadolinium oxyorthosilicate, LGSO. The scintillation light is
collected by arrays of PS-PMTs. This system is used mounted on an X-ray mammography unit,
although the PEM detector heads must be removed to acquire the X-ray image. The distance
between the detector heads can be adjusted to match the size of the breast. Image reconstruction
is performed by means of the backprojection scheme. The image spatial resolution varied from
4.8 mm to 6 mm, depending on the acceptance angles of the lines of response. An image of the
system can be seen in Figure 8.
A pilot clinical trial was performed using this system [34]. This trial included 23 patients with
suspected breast malignancies. Therefore, it does not provide meaningful information
concerning the specificity of the technique. In this study, where the majority of the evaluated
lesions had diameters smaller than 2.5 cm, PEM presented a sensitivity of 86%. The size of the
three malignant lesions that PEM was unable to detect varied from 8 mm to 15 mm. The system
was able to detect a 4 mm DCIS that was not detected by mammography.
3.5. The maxPET system
A dedicated PET camera for mammary and axillary region imaging, maxPET, was designed
and constructed at the Crump Institute for Biological Imaging [35]. This group used an
alternative scheme to couple the crystal arrays to the PMT’s, in order to avoid the problems
associated with the inactive area near the PMT edges. The maxPET system consisted of two
15×15 cm2 planar scintillation detector plates, each composed of several modular detectors.
The detectors are composed of arrays of 3×3×20 mm3 LSO crystals, each crystal array being
coupled to an optical fiber which in turn is coupled to a PS-PMT. The use of the optical fiber
allows the exact match between the crystal area and the active PMT dimensions, thus avoiding
gaps between detector modules. It also provides better imaging close to the chest wall, since
the plates are active out to the edge of the field-of-view. The main disadvantage of the fiber-
optic coupling is the loss of scintillation light.
Figure 8. Image of the Duke University - Jefferson Laboratory PEMsystem positioned in a mammography unit. The




The two detector plates can be mounted in a gantry allowing variable plates separation,
detector plates rotation and angular motion. Based on Monte Carlo simulation, the expected
intrinsic spatial resolution of the scanner was about 2.3 mm [36]. A prototype of this system
was assembled but, to our knowledge, no clinical test were ever performed.
A second prototype of this detector was build, with modified geometry and electronics. The
integration of this system with a dedicated CT system was exploited [37].
3.6. The LBNL PEM system
The PEM scanner developed at the Lawrence Berkeley National Laboratory (LBNL) has two
major differences from the PEM scanners described here: it has a rectangular geometry, with
four detector plates surrounding the breast and it has Depth of Interaction measurements
capabilities [38].
The system uses a 6 ns time window and has 5% sensitivity at the center of the FOV. The
measured spatial resolution of the scanner is almost uniform in the entire field-of-view,
ranging from 1.9 mm FWHM at the FOV centre to 2.1 mm at the FOV corner [38]. Images of a
mini-Derenzo phantom show that the smallest lesion resolved by the system is 2.4 mm in
diameter.
In the context of the development of this scanner, a simulation study was done to compare the
presented rectangular detector configuration with a dual stationary detector system, such as
some of the systems presented above. For such purpose it was used the Fisher information
matrix, an analytical computation that allows to characterize how easily a change of one
parameter in the source distribution can be identified from the measured data [40]. This study
has shown that the rectangular system with Depth of Interaction capability has a higher signal-
to-noise ratio for detection tasks and a lower bias at a given noise level for quantitation tasks.
It is worth stressing that this study did not include the case of a rotating dual head scanner [39].
The LBNL PEM system consists of four detector plates that cover a rectangular 8.2×6.0×5.0
cm3 field of view. The detector modules contain arrays of 3×3×30 mm3 LSO crystals that are
coupled to a single photomultiplier tube (PMT) in one end and to a photodiode array (PD) on
the other end. The ratio between the signals of the PMT and the PD allow the estimation of the
Depth of Interaction of the photon [41]. The achieved DOI resolution ranges from 6 mm FWHM
at the PD end to 11 mm FWHM at the PMT end [42].
The image reconstruction task for this scanner has been subject of an intense work. In an initial
stage, image reconstruction was performed with a filtered backprojection based reconstruction
algorithm that took into account the existence of DOI information and the irregular angular
sampling of the scanner [43, 44]. Later, a list mode penalized maximum likelihood algorithm
using Gaussian priors was developed [40, 45, 46]. A Monte Carlo based scatter correction
algorithm was also developed [46]. To our knowledge, this scanner has never been tested with
clinical data.
3.7. The YAP-PEM system
The YAP-PEM prototype was developed within a collaboration of the Italian Universities of
Pisa, Ferrara, Bologna and Roma [47]. The technology of this device derives from a small animal
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scanner previously developed by the group. The YAP-PEM scanner has been designed with
the aim of detecting 5 mm breast lesions in diameter and an activity ratio of 10:1 between the
cancer and the breast tissue. The device is composed of two stationary detector heads made
of yttrium aluminium perovskite (YAlO3) scintillators doped with cerium (YAP:Ce). This is a
scintillator crystal that produces a light output of about 20 photons/keV, has a decay constant
of 30 ns and a density of 5.4 g/cm3 [48]. It has, however, a low Z number. Each detector head
has a detection area of 6×6 cm2 that comprises 30×30 detection elements with 2×2×30 mm3 each.
The system uses PS-PMTs to collect the scintillation light. The distance between the detectors
can range from 5 to 10 cm, depending on the breast compression used.
For image reconstruction purposes, the ML-EM algorithm has been adapted to the planar
nature of the acquired data, in order to obtain a pseudo-tomographic imaging method [49].
This method works on data that is converted into histograms that are indicated for planar data.
These are known as planograms [50]. Geometrical symmetries are used to speed up the
computations.
Monte Carlo simulation and image reconstruction studies performed for the YAP-PEM
scanner indicate that the scanner is expected to have capability of discriminating 5 mm tumors
in a target-to-background ratio of 10:1. However, due to the planar nature of the data, if two
sources lie on the same axial plane, the system cannot discriminate them, as it can be seen in
Figure 10.
Figure 9. Phantom images obtained with the YAP-PEM prototype. Due to the planar nature of the scanner’s data, if
two sources lie on a same axial plane, the system cannot discriminate them. From [49].
3.8. The Clear-PEM system
The Clear-PEM system was developed within the framework of the CrystalClear collaboration,
in CERN. The system, which was designed to allow the examination of the breast and the axilla
regions, is composed of a dual-plate detector head that is housed in a robotic mechanical
gantry, as represented in Figure 11. For the breast examination, the patient lays in the prone
position with the breast hanging through an aperture in the patient. The two detector heads
are positioned in each side of the breast, as represented in Figure 11, and the projection data
are acquired at several angular positions. The detector heads can be positioned at different




Figure 10. Representation of the Clear-PEM system.From [51].
The detector heads cover a 16.2×14.1 cm2 FoV. Each detector head holds 96 detector modules,
is constituted of a total of 3072 LYSO:Ce crystals, each crystal having 2×2×20 mm3. A scheme
of a detector head is shown in Figure 12a. The distribution of the crystals within, the detector
plates is as follows. Each detector plate is constituted of a set of four structures named
supermodules, each one with 14×4 cm2, placed side by side. Each supermodule is composed
of 12×2 modules that, in turn, are composed of an array of 4×8 LYSO:Ce crystals. Therefore,





Figure 11. Clear-PEM detectors. a) Representation of a Clear-PEM detector head, with an highlighted detector super‐
module. From [51]. b) Representation of a Clear-PEM detector module with the double readout scheme. From [52].
The readout of each module is performed by two 32-pixel avalanche photodiodes that are
optically coupled to each side of the module, as shown in Figure 12b. This double readout
scheme allows the DOI measurement. The DOI coordinate within the crystal is estimated from
the asymmetry of the collected light at the top and bottom APD pixels. Experimental results
have shown that, with this scheme, it is possible to obtain a 2 mm FWHM DOI resolution [53].
This measurement is important since it increases the uniformity all over the field-of-view of
the scanner. This feature is not common in the universe of the positron emission mammogra‐
phy dedicated scanners and therefore it is perhaps one of the most important characteristics
of this scanner. The processing of the detector analogical signals, including the readout, the
low noise amplification, the sampling and the storage are implemented in dedicated ASICs
(Application Specific Integrated Circuits) integrated in the detection plates. The output
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analogue sampled pulses are digitized by Analogue Digital Converters (ADC) and transmitted
to the data acquisitions system (DAQ). This system, based on FPGA (Field Programmable Gate
Arrays), is responsible for the data reduction and storage. Data is send from here to a trigger
system that selects two-photon events in coincidence within a programmable timing window
and, at each trigger, the relevant data frames are send to the acquisition PC where energy and
time information are analyzed [54]. For events with more than one active crystal in a detector
head, due to Compton scattering, an event reconstruction position algorithms is used to assign
the coordinates of the interaction. Those events that are within the selected energy window
are validated, their final coordinates being used to define the LORs that are stored in a list-
mode file [53]. Images are reconstructed using 3D statistical iterative algorithms or 2D algebraic
techniques [55–57]. Phantom studies showed that the scanner is suitable for milimetric tumor
detection; Derenzo phantom studies showed that lesions up to 2 mm in diameter can be clearly
seen; a gelatin breast phantom indicated that lesions up to 3 mm in diameter can be detected.
The first prototype, installed at the Institute of Nuclear Sciences Applied to Health, Coimbra,
Portugal, was used for the first tests in a preclinical environment [58].
More  recently,  the  ClearPEM  scanner  has  been  used  to  create  a  multimodal  PEM  and
ultrasound scanner [59]. The aim of this system is to provide high resolution, high sensitivity
and high specificity  metabolic  information from PEM matched with  3D high resolution
anatomic  information.  The  new  ClearPEM-Sonic  scanner  also  provides  elastographic
information  from  ultrasound,  further  improving  the  specificity  of  the  multimodality
scanner. This second prototype is installed at the Hôpital Nord, in Marseille, France, and
has confirmed a spatial resolution of about 1.5 mm in phantom studies. The system allows
the  co-registration  of  US/ClearPEM  and  elastography/ClearPEM  with  an  alignment
precision of about 2 mm. The first clinical trial has confirm the ability to detect very small
lesions only seen by MRI, although lesions very close to the chest wall are left undetect‐
ed [60].
3.9. The MAMMI system
MAMMI (MAMmography with Molecular Imaging) is a dedicated breast PET, commercial‐
ized  by  Oncovision,  which  has  certification  in  Europe  and  has  recently  received  FDA
approval [61].
Instead of the more often used small pixelated crystal arrays, this scanner uses continuous
LYSO crystals coupled to PSPMTs.
The MAMMI prototype is a full ring PET consisting on 12 detector modules forming a
dodecagon with a scanner aperture of 186 mm [12]. Each detector module uses 10 mm thick
scintillation crystals with 40x40mm2 face. The back face of the crystals are coupled to the PS-
PMTs. The detector has a 18% energy resolution at 511 keV, an intrinsic resolution of 1.6 mm
and a DOI resolution of 4 mm.
The system aperture provides a 170 mm diameter FoV. The coincidences are allowed between
a detector module and its seven opposite modules, providing a transaxial FoV aperture of 170




of the ring detector in step and shoot mode to increase the axial FoV to 170 mm. A timing
window of 5 ns is used.
During image reconstruction the crystal faces are discretized into 2x2 mm2 pixels. Images are
reconstructed with standard 3D ML-EM with a voxel size of 1x1x1 mm3. The system matrix
was obtained through calculation of the solid angle of every voxel with respect to the detection
surface. Image reconstruction takes into account dead time, scatter and random events
correction. A method for attenuation correction without a transmission scan has been devel‐
oped and tested with the system [62].
Patients are imaged in the prone position, which is possible due to the existence of a breast
aperture in the patient table. This allows to image regions close to the chest wall without breast
compression.
The preliminary results using a 1 mm in diameter 22Na point like source results of 1.6 mm
FWHM axial and 1.9 transaxial in the center of the FoV and less than 3 mm FWHM in most
other parts of the FoV (axial) [12, 63]. The system sensitivity at the FoV center and with a wide
energy window of 250-759 keV is 1 %.
A pilot study was recently conducted with 32 invasive breast cancer patients to assess the
feasibility of the system for tumor detection and characterization [64]. The system sensitivity
for primary tumor visualization was 97%, which equals whole body PET-CT in the same study.
This included lesions close to the chest wall.
4. Conclusions
With two commercially available PEM scanners, there is now data from several clinical studies
that confirm the high sensitivity and specificity values for PEM in different clinical situations
[65, 66]. These data also allow a direct comparison with other techniques such as PET and MRI
and seem to indicate that the promise of molecular imaging with dedicated instruments as a
valuable adjunct technique for mammography holds true.
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